SNHG1 , interacting with SND1 , contributes to sorafenib resistance of liver cancer cells by increasing m6A ‐mediated SLC7A11 expression and promoting aerobic glycolysis
Environmental Toxicology · 2024-03 · 39 (3) · 1269-1282
DOI: 10.1002/tox.24014 ↗Kurz gefasst
Fachartikel in der Zeitschrift Environmental Toxicology, online erschienen am 06.11.2023. Verfasst von Rong Li und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Anesthesiology, The Second Affiliated Hospital of Xi'an Jiaotong University, Xi'an Jiaotong University, Xi'an, People's Republic of Chi…. Hauptthemen laut MEDLINE: MicroRNAs, RNA, Long Noncoding, Liver Neoplasms. Die Arbeit wurde bisher 17-mal zitiert (Crossref) und nennt 24 Literaturangaben. Gefördert von: Fundamental Research Funds for the Central Universities, Key Research and Development Plan of Shaanxi Province, Natural Science Foundation of Shaanxi Province.
Abstract (Originalsprache)
Aerobic glycolysis plays an important role in multidrug resistance of cancer cells. Here, we screened different expressed lncRNAs associated with sorafenib resistance of liver cancer cells, by intersecting the bioinformatics analyses of TCGA and GEO (the GSE62813 dataset) databases. Our results revealed that the 18 upregulated lncRNAs in the intersection are associated with and enriched in metabolism of small molecule organic acids, suggesting their potential in glycolysis. The lncRNA small nucleolar RNA host gene 1 (Snhg1) was chosen as a potential regulator of aerobic glycolysis in liver cancer cells, for its significant promotion on lactate production. Gain‐ and loss‐of‐function experiments mediated by Crispr‐Cas9 technique in HepG2 cells indicated that Snhg1 promoted cell proliferation, invasion, sorafenib resistance, and aerobic glycolysis. In the mechanism exploration, we found that Snhg1 can interact with SND1 protein, a famous RNA binding protein and recently identified “Reader” of N6‐methyladenosine (m6A). SND1 was demonstrated to be positively regulated by Snhg1 and had similar promoting effects on proliferation, invasion, sorafenib resistance, and aerobic glycolysis of HepG2 cells. SND1 bound with and promoted the expression of SLC7A11, an aerobic glycolysis regulator. Furthermore, either silencing SLC7A11 or blocking aerobic glycolysis with 2‐deoxy‐ d ‐glucose (2‐DG) was able to reverse the promotion of Snhg1 overexpression on malignancy, sorafenib resistance, and aerobic glycolysis of HepG2 cells. Finally, in a liver cancer xenograft mouse model, we found that formed tumors with Snhg1‐knocked‐down HepG2 cells were more sensitive to sorafenib administration. Altogether, SNHG1 contributes to sorafenib resistance of liver cancer cells by promoting SND1‐m6A‐SLC7A11‐mediated aerobic glycolysis.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Anesthesiology, The Second Affiliated Hospital of Xi'an Jiaotong University, Xi'an Jiaotong University, Xi'an, People's Republic of China.
- Department of General Surgery, The Second Affiliated Hospital of Xi'an Jiaotong University, Xi'an Jiaotong University, Xi'an, People's Republic of China.
- Department of Gastroenterology, The Second Affiliated Hospital of Xi'an Jiaotong University, Xi'an Jiaotong University, Xi'an, People's Republic of China.
- Department of Oncology, The Second Affiliated Hospital of Xi'an Jiaotong University, Xi'an, Shaanxi, People's Republic of China.
ORCID-Profile: Meng Xu
Förderung
- Fundamental Research Funds for the Central Universities
- Key Research and Development Plan of Shaanxi Province
- Natural Science Foundation of Shaanxi Province
- Shaanxi Province Youth Science and Technology New Star Plan
- The National Natural Science Foundation of China
- Youth Talent Referral Program of Science and Technology Association in Shaanxi Province
Zitieren
APA
Li, R., Li, S., Shen, L., Li, J., Zhang, D., Yu, J., Huang, L., Liu, N., Lu, H., & Xu, M. (2024). SNHG1 , interacting with SND1 , contributes to sorafenib resistance of liver cancer cells by increasing m6A ‐mediated SLC7A11 expression and promoting aerobic glycolysis. Environmental Toxicology, 39(3), 1269-1282. https://doi.org/10.1002/tox.24014
Vancouver
Li R, Li S, Shen L, Li J, Zhang D, Yu J, et al. SNHG1 , interacting with SND1 , contributes to sorafenib resistance of liver cancer cells by increasing m6A ‐mediated SLC7A11 expression and promoting aerobic glycolysis. Environmental Toxicology. 2024;39(3):1269-1282. doi:10.1002/tox.24014
BibTeX
@article{Li2024,
author = {Li, Rong and Li, Shunle and Shen, Lin and Li, Junhui and Zhang, Di and Yu, Jinmin and Huang, Lanxuan and Liu, Na and Lu, Hongwei and Xu, Meng},
title = {SNHG1 , interacting with SND1 , contributes to sorafenib resistance of liver cancer cells by increasing m6A ‐mediated SLC7A11 expression and promoting aerobic glycolysis},
journal = {Environmental Toxicology},
year = {2024},
volume = {39},
number = {3},
pages = {1269--1282},
doi = {10.1002/tox.24014}
}
EUVIMED